Medical cannabis in the UK: From principle to practice

Authors: Anne Katrin Schlag, David S Baldwin, Michael Barnes, Steve Bazire, Rachel Coathup, H Valerie Curran, Rupert McShane, Lawrence D Phillips, Ilina Singh, David J Nutt Published: June 10, 2020 Read the full paper here (open access) Drug Science submits it's finding concerning the UK Medical cannabis industry. In our recent peer-reviewed publication, Drug Science  …

Statement on the dangers posed by e-cigarettes

Drug Science stands by its e-cigarette analysis from 2014, any way of radically reducing the death toll from tobacco would be a worldwide public health triumph. e-cigarettes are not the solution to end the ever-increasing death toll caused by tobacco. However, they have proven to be an incredibly effective tool for tens of thousands of  …


First safety study of MDMA-assisted psychotherapy in patients with alcohol use disorder

Authors: Ben Sessa, Chloe Sakal, Steve O’Brien and David Nutt Published: July 15, 2019 Read the full paper here (open access) We present the preliminary data in the Bristol-Imperial MDMA-for-Alcoholism (BIMA) study, an ongoing open-label safety and tolerability proof of concept study exploring the potential role for 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in treating patients with alcohol  …

A multi-criterion decision analysis applied to alcohol and cannabis regulation

Authors: Ole Rogeberg, Daniel Bergsvik, Lawrence D. Phillips, Jan van Amsterdam, Niamh Eastwood, Graeme Henderson, Micheal Lynskey, Fiona Measham, Rhys Ponton, Steve Rolles, Anne Katrin Schlag, Polly Taylor, and David Nutt Published: February 17, 2018 In collaboration with drug experts in Norway and the UK, multi-criteria decision analysis has been applied to evaluating drug policies  …

Ketamine treatment for depression

A review and analysis of the ethical considerations in off-label ketamine use for severe, treatment-resistant depression. The review concludes that further restrictions around ketamine are not neccesary and provides a set of recomendations for oversight bodies that would support safe, effective, and ethical use. Read it here

Ketamine as an essential medicine

Authors: Polly Taylor, David Nutt, Val Curran, Rudi Fortson, and Graeme Henderson Published: March 11, 2016 A letter to The Lancet endorsing the WHO Expert Committee on Drug Dependence's conclusion that concerns over recreational ketamine abuse in no way outweigh ketamine's role as a life-saving anasthetic and essential medicine. For open-access to the full report  …

Khat and alcohol harm comparison

As the khat ban approached, DrugScience commissioned a review of khat harms, following the detailed and rigorous report from the UK Government Advisory Council on the Misuse of Drugs earlier that year. DrugScience's review provided independent corroboration of the ACMD’s findings that the harms of khat cannot justify a ban and that community measures should  …

Harms of nicotine-containing products

Around the world, politicians are working to ban e-cigarette marketing, limit their nicotine content, prohibit use in public buildings, and even to ban them entirely. There remains a need for policy makers to become better informed of the relative harms of nicotine delivery systems in order to build a regulatory framework that minimises harm. The  …


Drug Science ketamine review

Authors: Celia J.  A. Morgan and H. Valerie Curran Published: July 21, 2011 The first comprehensive review of the drug since its classification, DrugScience's ketamine review highlighted harms such as neurological and bladder damage. For open-access to the full report of this research, see below: Access full publication

MCDA Comparison of Drug and Alcohol Harms in the UK

Authors: David J Nutt, Leslie A King, and Lawrence D Phillips Published: November 1, 2010 An assessment of the various harms of drugs used recreationally in the UK using multi-criteria decision analysis (MCDA) – a method that uses relevant experts’ knowledge and experience to assess the actual and relative harms - download the paper here.  …